Detrothyronine | CAS#5714-08-9 | biochemical

MedKoo Cat#: 592457 | Name: Detrothyronine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Detrothyronine is a biochemical.

Chemical Structure

Detrothyronine

CAS#5714-08-9

Theoretical Analysis

MedKoo Cat#: 592457

Name: Detrothyronine

CAS#: 5714-08-9

Chemical Formula: C15H12I3NO4

Exact Mass: 650.7900

Molecular Weight: 650.98

Elemental Analysis: C, 27.68; H, 1.86; I, 58.48; N, 2.15; O, 9.83

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Detrothyronine; NSC 46046; NSC-46046; NSC46046

IUPAC/Chemical Name

Alanine, 3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, D- (8CI)

InChi Key

AUYYCJSJGJYCDS-LBPRGKRZSA-N

InChi Code

InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1

SMILES Code

N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 650.98 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Hine C, Kim HJ, Zhu Y, Harputlugil E, Longchamp A, Matos MS, Ramadoss P, Bauerle K, Brace L, Asara JM, Ozaki CK, Cheng SY, Singha S, Ahn KH, Kimmelman A, Fisher FM, Pissios P, Withers DJ, Selman C, Wang R, Yen K, Longo VD, Cohen P, Bartke A, Kopchick JJ, Miller R, Hollenberg AN, Mitchell JR. Hypothalamic-Pituitary Axis Regulates Hydrogen Sulfide Production. Cell Metab. 2017 Jun 6;25(6):1320-1333.e5. doi: 10.1016/j.cmet.2017.05.003. PubMed PMID: 28591635; PubMed Central PMCID: PMC5722247. 2: Chaker L, Baumgartner C, den Elzen WP, Collet TH, Ikram MA, Blum MR, Dehghan A, Drechsler C, Luben RN, Portegies ML, Iervasi G, Medici M, Stott DJ, Dullaart RP, Ford I, Bremner A, Newman AB, Wanner C, Sgarbi JA, Dörr M, Longstreth WT Jr, Psaty BM, Ferrucci L, Maciel RM, Westendorp RG, Jukema JW, Ceresini G, Imaizumi M, Hofman A, Bakker SJ, Franklyn JA, Khaw KT, Bauer DC, Walsh JP, Razvi S, Gussekloo J, Völzke H, Franco OH, Cappola AR, Rodondi N, Peeters RP; Thyroid Studies Collaboration. Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis. J Clin Endocrinol Metab. 2016 Nov;101(11):4270-4282. Epub 2016 Sep 7. PubMed PMID: 27603906; PubMed Central PMCID: PMC5095234. 3: Yang S, Shi FT, Leung PC, Huang HF, Fan J. Low Thyroid Hormone in Early Pregnancy Is Associated With an Increased Risk of Gestational Diabetes Mellitus. J Clin Endocrinol Metab. 2016 Nov;101(11):4237-4243. Epub 2016 Sep 1. PubMed PMID: 27583471. 4: Pearce SH, Razvi S, Yadegarfar ME, Martin-Ruiz C, Kingston A, Collerton J, Visser TJ, Kirkwood TB, Jagger C. Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study. J Clin Endocrinol Metab. 2016 Nov;101(11):4385-4394. Epub 2016 Aug 23. PubMed PMID: 27552542; PubMed Central PMCID: PMC5095241. 5: Unüvar T, Anık A, Catlı G, Esen I, Abacı A, Büyükgebiz A, Böber E. Isolated hyperthyrotropinemia in childhood obesity and its relation with metabolic parameters. J Endocrinol Invest. 2014 Sep;37(9):799-804. doi: 10.1007/s40618-014-0100-y. Epub 2014 Jun 12. PubMed PMID: 24920280. 6: Kundu S, Pramanik M, Roy S, De J, Biswas A, Ray AK. Maintenance of brain thyroid hormone level during peripheral hypothyroid condition in adult rat. Life Sci. 2006 Sep 5;79(15):1450-5. Epub 2006 Apr 25. PubMed PMID: 16698041. 7: Visser TJ. The elemental importance of sufficient iodine intake: a trace is not enough. Endocrinology. 2006 May;147(5):2095-7. PubMed PMID: 16617153. 8: Ercan O. Thyroid Hormone Resistance in children. Pediatr Endocrinol Rev. 2003 Dec;1 Suppl 2:191-8; discussion 198. Review. PubMed PMID: 16444158. 9: Denke MA. Diet, lifestyle, and nonstatin trials: review of time to benefit. Am J Cardiol. 2005 Sep 5;96(5A):3F-10F. Review. PubMed PMID: 16126018. 10: Sarkissian G, Dace A, Mesmacque A, Bony-Trifunovic H, Malezet-Desmoulins C, Torresani J, Margotat A. A novel resistance to thyroid hormone associated with a new mutation (T329N) in the thyroid hormone receptor beta gene. Thyroid. 1999 Feb;9(2):165-71. PubMed PMID: 10090317. 11: Lin HY, Martino LJ, Wilcox BD, Davis FB, Gordinier JK, Davis PJ. Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression. J Immunol. 1998 Jul 15;161(2):843-9. PubMed PMID: 9670962. 12: Bommer C, Werle E, Walter-Sack I, Keller C, Gehlen F, Wanner C, Nauck M, März W, Wieland H, Bommer J. D-thyroxine reduces lipoprotein(a) serum concentration in dialysis patients. J Am Soc Nephrol. 1998 Jan;9(1):90-6. PubMed PMID: 9440092. 13: Pohlenz J, Knöbl D. Treatment of pituitary resistance to thyroid hormone (PRTH) in an 8-year-old boy. Acta Paediatr. 1996 Mar;85(3):387-90. PubMed PMID: 8696005. 14: Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit. A new look at old data. Circulation. 1995 Apr 15;91(8):2274-82. PubMed PMID: 7697857. 15: Narihara R, Hirouchi M, Ichida T, Kuriyama K, Roberts E. Effects of thyroxine and its related compounds on cerebral GABA receptors: inhibitory action on benzodiazepine recognition site in GABAA receptor complex. Neurochem Int. 1994 Nov;25(5):451-4. PubMed PMID: 7849573. 16: Karlsson FA, Burman P, Kämpe O, Westlin JE, Wide L. Large somatostatin-insensitive thyrotrophin-secreting pituitary tumour responsive to D-thyroxine and dopamine agonists. Acta Endocrinol (Copenh). 1993 Oct;129(4):291-5. PubMed PMID: 7901958. 17: Hamon P, Dingeon B, Jiang NS, Orgiazzi J. Purified D-thyroxine in athyreotic patients. Lancet. 1993 Jun 5;341(8858):1477. PubMed PMID: 8099168. 18: Schwartz ID, Bercu BB. Dextrothyroxine in the treatment of generalized thyroid hormone resistance in a boy homozygous for a defect in the T3 receptor. Thyroid. 1992 Spring;2(1):15-9. PubMed PMID: 1525565. 19: Aguilar Diosdado M, Escobar-Jimenez L, Fernandez Soto ML, Garcia Curiel A, Escobar-Jimenez F. Hyperthyroidism due to familial pituitary resistance to thyroid hormone: successful control with 3, 5, 3' triiodothyroacetic associated to propranolol. J Endocrinol Invest. 1991 Sep;14(8):663-8. PubMed PMID: 1774450. 20: Sandhu GS, Steele R, Gonnella NC. Effect of L-thyroxine (LT4) and D-thyroxine (DT4) on cardiac function and high-energy phosphate metabolism: a 31P NMR study. Magn Reson Med. 1991 Mar;18(1):237-43. PubMed PMID: 2062236.